期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

呼吸道合胞病毒感染及反义基因治疗的研究进展 被引量：2

原文传递
导出
摘要 一、呼吸道合胞病毒（respiratory syncytial virus，RSV）感染及治疗现状 1．RSV基因结构与蛋白功能：RSV属于副黏病毒科，肺炎病毒属，为非节段性单股负链RNA病毒，含有大约15000个核苷酸，其基因顺序依次为：3′NS1-NS2-N-P-M-SH-G-F-M2-（M2-1／M2-2）-L-5′，共编码11个病毒蛋白，分别为：
作者 崔玉霞 杨锡强
机构地区 重庆医科大学附属儿童医院免疫室
出处 《中华儿科杂志》 CAS CSCD 北大核心 2006年第8期629-632,共4页 Chinese Journal of Pediatrics
基金 国家自然科学基金(30340045)
关键词 呼吸道合胞病毒感染 反义基因治疗 负链RNA病毒 治疗现状 副黏病毒 蛋白功能 基因结构 肺炎病毒 基因顺序 病毒蛋白
分类号 R725.6 [医药卫生—儿科] R735.7 [医药卫生—肿瘤]
  • 相关文献

参考文献40

  • 1Collins PL,Dickens LE,Buckler-White A,et al.Nucleotides sequence for the gene junction of human respiratory syncytial virus reveal the distinctive features of intergenic structure and gene order.Proc Natl Acad Sci USA,1986,83:4594-4598.
  • 2Collins PL,Hill MG,Cristina J,et al.Transcription elongation factor of respiratory syncytial virus,a nonsegmented negative-strand RNA virus.Proc Natl Acad Sci USA,1996,93:81-85.
  • 3Grosfeld H,Hill MG,Collins PL.RNA replication by respiratory syncystial virus (RSV) is directed by the N,P,and L proteins;transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA.J Virol,1995,69:5677-5686.
  • 4Bermingham A,Collins PL.The M2-2 protein of human respiratory syncystial virus is a regulatory factor involved in the balance between RNA replication and transcription and transcription.Proc Natl,1999,96:11259-11264.
  • 5Prober CG,Sullender WM.Advancers in prevention of respiratory syncytial virus infections.J Pediater,1999,135:546-558.
  • 6Whitehead SS,Bukreyev A,Teng MN,et al.Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees.J Virol,1999,73:3438-3442.
  • 7陈慧中.呼吸道合胞病毒感染的防治[J].实用儿科临床杂志,2001,16(3):176-177. 被引量：47
  • 8Maggon k,Barik S.New drugs and treatment for respiratory syncytial virus.Rev Med Virol,2004,14:149-168.
  • 9Cramer H.Antisense approaches for inhibiting respiratory syncystial virus.Expert Opin Biol Ther,2005,5:207-220.
  • 10Gern JE.Mechanisms of virus-induced asthma.J Pediatr,2003,142:9-13.

二级参考文献79

  • 1Piedra PA. Respiratory syncytial virus vaccine: recent developments. Pediatr Infect Dis J. 2000. 19:805-808.
  • 2Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Pro Nat] Acad Sci USA. 1997.94:4262-4266.
  • 3Player MR, Barnard DL, Torrence PF. Potent inhibition of respiratory syncytial virus replication using a2-SA-antisense chimera targeted to signals within the virus genomic RNA. Proc Natl Acad Sci USA, 1998, 95:8874-8879.
  • 4Cirino NM, Li G, Xiao W, et al. Targeting RNA decay with 2',5'oligoadenylate-antissense in respiratory syncytial virus -infected cells.Proc Natl Acad Sci USA. 1997.94:1937-1942.
  • 5Wu Y, Yu I, Mcmahon R, et al. Inhibition of bcr-abl oncogenr expression by novel deoxyribozyme. Hum Gene Ther, 1999, 10:2847 -2857.
  • 6Finkle E. DNA cuts its teeth-as an enzyme. Science, 1999, 286:2441-2442.
  • 7Lowe HC, Fahmy RG, Kavurma MM, et al. Catalytic oligodeoxynucleotides defme a key regulatory role for early growth response factor-1 in the porcine model of coronary in-stent restenosis.Circ Res , 2001,89:670-677.
  • 8Sriram B, Baneljea AC. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression. Biochem J, 2000, 352( Pt 3) :667-673.
  • 9Unwalla H, Banerjea AC. Inhibition of HIV-1 gene expression by novel macrophage-tropic DNA enzymes targeted to cleave HIV-1 TAT/Rev RNA. Biochem J, 2001, 357(Pt 1) :147-155.
  • 10Toyoda T, Imamura y, Takaku H, et al. Inhibition of influenza virus replication in cultured cells by RNA-cleaving DNA enzyme.FEBS Lett, 2000, 481:113-116.

共引文献64

同被引文献27

  • 1林立,李昌崇.呼吸道合胞病毒感染发病机制[J].中华儿科杂志,2006,44(9):673-675. 被引量：45
  • 2徐霞,隋在云,隋丽云.金贝清肺颗粒体内抗呼吸道合胞病毒作用的实验研究[J].时珍国医国药,2007,18(2):403-404. 被引量：7
  • 3Fattouh AM, Mansi YA, Elanany MG, et al. Acute lower respiratory tract infection due to respiratory syncytial virus in a group of egyptian children under 5 years Of age [J]. Ital J Pediatr,2011,37(1):14.
  • 4Schiller O, Levy I, Pollak U, et al. Central apnoeas in infants with bronchiolitis admitted to the paediatrie intensive care unit [J]. Acta Paediatr,2011,100(2):216-219.
  • 5Akiyama N, Segawa T, Ida H, et al. Bimodal effects of obesity ratio on disease duration of respiratory syncytial virus infection in children [M]. Allergol Int,2011.
  • 6Bertrand P, Aranibar H, Castro E, et al. Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchio- olitis [J]. Pediatric Pulmonol,2003,360(9327): 101-102.
  • 7Cade Brownlee KG, Corrway SP, et al. Randomised placebo-contr- olled trial of nebulised corticostrolitis in acute respiratory syneytial viral bronchiolitia [J]. Arch Dis Child,2000,82:126-130.
  • 8H. Cody Meissner, MD, Sarah S. Long. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. [J]. Pediatrics,2003,112(6): 1442-1446.
  • 9Duma MC, Knight DA, Waldman WJ. Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide [J]. Antivir Ther,2011,16(3):309-317.
  • 10Groothuis JR, Hoopes JM, Hemming VG. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis [J]. Adv Ther.,2011,28(2): 110-125.

引证文献2

二级引证文献4

中华儿科杂志
2006年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部